Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis

Experimental and Clinical Endocrinology and Diabetes

Volumn 108, Issue 2, 2000, Pages 110-119

  Minich, W B ^a   Loos, U ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Autoantibodies; Graves' disease; Immunoprecipitation; TSH receptor

Indexed keywords

AMINO ACID; AUTOANTIBODY; CHORIONIC GONADOTROPIN RECEPTOR; COMPLEMENTARY DNA; CYCLIC AMP; HYBRID PROTEIN; IMMUNOGLOBULIN; LUCIFERASE; PROLACTIN; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY;

AMINO TERMINAL SEQUENCE; ANTIBODY DETECTION; ARTICLE; BIOASSAY; CHIMERA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; ENZYME ACTIVITY; GRAVES DISEASE; HELA CELL; HUMAN; IMMUNOPRECIPITATION; LUMINESCENCE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; VACCINIA VIRUS;

AUTOANTIBODIES; EPITOPES; GRAVES DISEASE; HELA CELLS; HUMANS; IMMUNOGLOBULINS, THYROID-STIMULATING; IMMUNOSORBENT TECHNIQUES; LUCIFERASES; LUMINESCENT MEASUREMENTS; RECEPTORS, LH; RECEPTORS, THYROTROPIN; RECOMBINANT FUSION PROTEINS;

EID: 0034056124     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-5804     Document Type: Article

References (22)

1. Costagliola S, Morgenthaler NG, Hoermann R, Bodenhoop K, Struck J, Freitag R, Poertl S, Weglöhner W, Hollidt JM. Quadheck B, Dumont JE, Schumm-Draeger PM, Bergmann A, Mann K, Vassart G, Usadel K-H: Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. J Clin Endocrinol Metab 84: 90-97, 1999
2. Evans C, Morgenthaler NG, Lee S, Llewellyn DH, Clifton-Bligh R, John R, Lazarus JH, Chatterjee VKK, Ludgate M: Development of a luminescent bioassay for thyroid stimulating antibodies. J Clin Endocrinol Metab 84: 374-377, 1999
3. Grasso YZ, Kim MR, Falman C, Kohn LD, Tahara K, Gupta MK: Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors. Thyroid 9: 531-537, 1999
4. Kim WB, Cho BY, Park HY, Lee HK, Kohn LD, Tahara K, Koh CS: Epitopes for thyroid stimulating antibodies in Graves' sera: A possible link of heterogeneity to differences in response to antithyroid drug treatment. J Clin Endocrinol Metab 81: 1758-1767, 1996
5. Kim WB, Chung HK, Lee HK, Kohn LD, Cho BY: Changes in epitopes for thyroid-stimulating antibodies in Graves' disease sera during treatment of hyperthyroidism: Therapeutic implications. J Clin Endocrinol Metab 82: 1953-1959, 1997
6. Kohn LD, Shimura H, Shimura Y, Hidaka GC, Napolitano G, Ohmor M, Laglia G, Saji M: The thyrotropin receptor. Vitam Horm 50: 287-384, 1995
7. Metzger C, Michel D, Lüske A, Schlicht HJ, Mertens T: Human cytomegalovirus UL97 kinase confers ganciclovir susceptibility to recombinant vaccinia virus. J Virol 68: 8423-8427, 1994
8. Minich WB, Behr M, Loos U: Expression of a functional tagged human thyrotropin receptor in HeLa cells using recombinant vaccinia virus. Exp Clin Endocrinol Diabetes 105: 282-290, 1997
9. Minich WB, Weymayer JD, Loos U: Expression of a biotinylated human thyrotropin receptor in HeLa cells using recombinant vaccinia virus and its application for the detection of Graves' autoantibodies. Thyroid 8: 3-7, 1998
10. 125I-labeled human thyrotropin receptor and its use for the detection of pathological autoantibodies in Graves' patients' sera. J Endocrinol 160: 239-245, 1999
11. 125I-neutravidin. Exp Clin Endocrinol Diabetes 107: 555-560, 1999
12. Nagayama Y, Wadsworth HL, Russo D, Chasenbalk GD, Rapoport B: Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors. J Clin Invest 88: 336-340, 1991
13. Paschke R, Ludgate M: The thyrotropin receptor in thyroid diseases. N Engl J Med 337: 1675-1681, 1997
14. Rapoport B, Chasenbalk GD, Jaume JC, McLachlam SM: The thyrotropin (TSH)- hormone receptor: interaction with TSH and autoantibodies. Endocrinol Rev 19: 673-716, 1998
15. Refetoff S, Sunthornthepvarakul T, Gottschalk ME, Hayashi Y: Resistance to thyrotropin and other abnormalities of the thyrotropin receptor. Recent Prog Horm Res 51: 97-122, 1996
16. Shewring G, Rees Smith B: An improved radioreceptor assay for TSH receptor antibodies. Clin Endocrinol 17: 409-414, 1982
17. Tahara K, Ban K, Minegishi T, Kohn LD: Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients. Biochem Biophys Res Commun 179: 70-77, 1991
18. Tahara K, Ishikawa N, Yamamoto K, Hirai A, Ito K, Tamura Y, Yoshida S, Saito Y, Kohn LD: Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor. Thyroid 7: 867-877, 1997
19. Tonacchera M, Van Sande J, Parma J, Duprez L, Cetani F, Costagliola S, Dumont JE, Vassart G: TSH receptor and disease. Clin Endocrinol 44: 621-633, 1996
20. Tonacchera M, Costagliola S, Cetani F, Ducobu J, Stordeur P, Vassart G, Ludgate M: Patient with monoclonal gammopathy, thyrotoxicosis, pretibial myxedema and thyroid-associated ophthalmopathy; demonstration of direct binding of autoantibodies to the thyrotropin receptor. Eur J Endocrinol 134: 97-103, 1996
21. Vlase H, Nakashima M, Graves PN, Tomer Y, Morris JC, Davis TF: Defining the major antibody epitopes on the human thyrotropin receptor in immunized mice: evidence for intramolecular epitope spreading. Endocrinology 136: 4415-4423, 1995
22. Wallaschofski H, Paschke R: Detection of thyroid stimulating (TSAB)- and thyrotropin stimulating blocking (TSBAB) antibodies with CHO cell lines expressing different TSH-receptor numbers. Clin Endocrinol 50: 365-372, 1999